Location History:
- Braine le Chateau, BE (2007)
- Dilbeek, BE (2005 - 2008)
- Vilvoorde, BE (2004 - 2009)
Company Filing History:
Years Active: 2004-2009
Title: Didier Communi: Innovator in G-Protein Coupled Receptor Research
Introduction
Didier Communi is a notable inventor based in Vilvoorde, Belgium, recognized for his contributions to the field of biochemistry and pharmacology. With a total of nine patents to his name, he has made significant strides in the development of antibodies targeting G-protein coupled receptors.
Latest Patents
Among his latest patents is an innovative antibody against a G-protein coupled receptor that shows selective affinity for ATP. This invention encompasses isolated antibodies, both polyclonal and monoclonal, that specifically bind to this receptor. Additionally, he has developed a pharmaceutical composition that includes these antibodies, which can be pivotal in therapeutic applications. Another significant patent involves the natural ligand for the orphan G protein coupled receptor GPR86, along with methods for detecting the dysregulation of GPR86 activity.
Career Highlights
Throughout his career, Didier Communi has worked with various organizations, including Euroscreen S.A. His work has been instrumental in advancing the understanding of G-protein coupled receptors and their implications in various biological processes.
Collaborations
Didier has collaborated with esteemed colleagues such as Jean-Marie Boeynaems and Marc Parmentier, contributing to a rich exchange of ideas and research in the field.
Conclusion
Didier Communi's innovative work in the realm of G-protein coupled receptors and his numerous patents highlight his significant impact on biochemistry and pharmacology. His contributions continue to pave the way for advancements in therapeutic applications.